From Financing to Exit: What’s New for Life Sciences Companies?

Présentation


Programme

17.00 Registration
17.30 Panel discussion
19.00 Cocktail Reception

McDermott is pleased to invite you to a panel discussion to be held in our Paris office on May 23, immediately post-BioEquity – see our panel of outside experts listed below. Also, we have selected financing/exit specialists from McDermott’s BioEquity Team to be present for informal commentary.

Introduction

Emmanuelle Trombe, Partner, McDermott Will & Emery Paris

SPEAKERS

Rafaele Tordjman, Special Advisor, Sofinnova

Cédric Moreau, Managing Director, Oddo

Glyn Edwards, Chief Executive Officer, Summit Therapeutics plc

Jacky Vonderscher, Ph.D, Chief Executive Officer, Enyo Pharma SA

Paul Hadden, Managing Director, HealthCare Royalty Partners

Mark Selinger, Partner, McDermott Will & Emery New York

Kristian Werling, Partner, McDermott Will & Emery Chicago

Pour aller plus loin

Virtual Event / Speaking Engagements / December 1-3, 2021

EIT Health Catapult Awards

Virtual Conference / Speaking Engagements / November 4, 2021

65th Annual IP Law Conference | Vaccines, IP and Global Equity

Webinar / Dynamic Global Events / October 11-12, 2021

2nd REMS Virtual Summit

Webinar / McDermott Event / October 7, 2021

McDermott Paris Virtual Life Sciences Forum

Webinar / American Conference Institutes (ACI) / September 29-30, 2021

ACI's FDA Boot Camp